[Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
The article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases in the world and in Chile and the scientific information of the licensed HPV vaccines: Gardasil and Cervarix. Considering the available information, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases, summarizes its conclusions and makes recommendations for vaccination against HPV in Chile.
Abarca V
Katia
K
Departamento de Pediatría, Facultad de Medicina, Pontificia Universidad Católica de Chile. katia@med.puc.cl
Valenzuela B
M Teresa
MT
Vergara F
Rodrigo
R
Luchsinger F
Vivian
V
Muñoz M
Alma
A
Jiménez de la Jara
Jorge
J
Ripoll M
Erna
E
O'Ryan G
Miguel
M
D000293:Adolescent; D000328:Adult; D026683:Advisory Committees; D052685:Alphapapillomavirus / Q000276:immunology*; D002677:Chile / Q000453:epidemiology; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000276:immunology; D012955:Societies, Medical; D055815:Young Adult
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18